BTLS fundamentals
An in-depth look to BIOTALYS NV operating, investing, and financing activities
BTLS free cash flow for H2 23 is -9.56 M EUR. For 2023, BTLS free cash flow was -18.12 M EUR and operating cash flow was -17.78 M EUR.
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM